Sedative load and functional outcomes in community-dwelling older Australian men: The CHAMP study

Fundamental and Clinical Pharmacology

Volumn 28, Issue 1, 2014, Pages 10-19

  Gnjidic, Danijela ^a,b,c,d   Le Couteur, David G ^b,c   Hilmer, Sarah N ^a,b   Cumming, Robert G ^b,c,e   Blyth, Fiona M ^b,c   Naganathan, Vasi ^b,c   Waite, Louise ^b,c   Handelsman, David J ^b,c   J S , Bell ^f,g  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ANZAC Research Institute   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Adverse outcomes; Hypnotics and sedatives; Older men; Pharmacoepidemiology; Sedative load

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; ATROPINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; CABERGOLINE; CHOLINE; CLONIDINE; DOMPERIDONE; HOMATROPINE; HYPNOTIC SEDATIVE AGENT; METOCLOPRAMIDE; OPIATE; PERGOLIDE; PROCHLORPERAZINE; THALIDOMIDE; THEOPHYLLINE; TRIHEXYPHENIDYL;

ADL DISABILITY; AGED; ARTICLE; COGNITIVE DEFECT; COMMUNITY; COMPARATIVE STUDY; CONSCIOUSNESS DISORDER; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SEDATION; SEDATIVE LOAD SCORE; WALKING SPEED;

ADVERSE OUTCOMES; HYPNOTICS AND SEDATIVES; OLDER MEN; PHARMACOEPIDEMIOLOGY; SEDATIVE LOAD;

ACTIVITIES OF DAILY LIVING; AGED; AGING; AUSTRALIA; CROSS-SECTIONAL STUDIES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; RESIDENCE CHARACTERISTICS;

EID: 84892551005     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2012.01063.x     Document Type: Article

References (48)

1. McLachlan A.J., Pont L.G. Drug metabolism in older people-a key consideration in achieving optimal outcomes with medicines. J. Gerontol. A Biol. Sci. Med. Sci. (2012) 67 175-180.
2. Hilmer S.N., Gnjidic D., Abernethy D.R. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. J. Gerontol. A Biol. Sci. Med. Sci. (2012) 67 181-188.
3. Cooper R., Kuh D., Hardy R. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ (2010) 341 c4467.
4. Newman A.B., Kupelian V., Visser M. et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J. Gerontol. A Biol. Sci. Med. Sci. (2006) 61 72-77.
5. Guralnik J.M., Ferrucci L., Simonsick E.M., Salive M.E., Wallace R.B. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N. Engl. J. Med. (1995) 332 556-561.
6. Gray S.L., LaCroix A.Z., Hanlon J.T. et al. Benzodiazepine use and physical disability in community-dwelling older adults. J. Am. Geriatr. Soc. (2006) 54 224-230.
7. Hanlon J.T., Horner R.D., Schmader K.E. et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin. Pharmacol. Ther. (1998) 64 684-692.
8. Hindmarch I. Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder. Int. J. Clin. Prac. (2009) 63 1085-1094.
9. Hegerl U., Mergl R., Henkel V. et al. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression. Psychopharmacology (2005) 178 58-66.
10. Culang M.E., Sneed J.R., Keilp J.G. et al. Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am. J. Geriatr. Psychiatry (2009) 17 881-888.
11. Hilmer S.N., Gnjidic D. The effects of polypharmacy in older adults. Clin. Pharmacol. Ther. (2009) 85 86-88.
12. Gnjidic D., Cumming R.G., Le Couteur D.G. et al. Drug Burden Index and physical function in older Australian men. Br. J. Clin. Pharmacol. (2009) 68 97-105.
13. Gnjidic D., Bell J.S., Hilmer S.N., Lonnroos E., Sulkava R., Hartikainen S. Drug Burden Index associated with function in community dwelling older people living in Finland. Ann. Med. (2011) April 15 [Epub ahead of print]
14. Gnjidic D., Le Couteur D.G., Abernethy D.R., Hilmer S.N. Drug Burden Index and Beers criteria: Impact on functional outcomes in older people living in self-care retirement villages. J. Clin. Pharm. (2012) 52 258-265.
15. Gnjidic D., Hilmer S.N., Blyth F. et al. High risk prescribing and incidence of frailty among older community-dwelling men. Clin. Pharmacol. Ther. (2012) 91 521-528.
16. Boudreau R.M., Hanlon J.T., Roumani Y.F. et al. Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition study. Pharmacoepidemiol. Drug Saf. (2009) 18 916-922.
17. Bell J.S., Taipale H.T., Soini H., Pitkala K.H. Sedative load among long-term care facility residents with and without dementia: a cross-sectional study. Clin. Drug Investig. (2010) 30 63-70.
18. Taipale H.T., Bell J.S., Gnjidic D., Sulkava R., Hartikainen S. Muscle strength and sedative load in community-dwelling people aged 75 years and older: a population-based study. J. Gerontol. A Biol. Sci. Med. Sci. (2011) 66 1384-1392.
19. Taipale H.T., Bell J.S., Gnjidic D., Sulkava R., Hartikainen S. Sedative load among community-dwelling people aged 75 years and older: association with balance and mobility. J. Clin. Psychopharmacol. (2012) 32 218-224.
20. Cumming R.G., Handelsman D., Seibel M.J. et al. Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP). Int. J. Epidemiol. (2009) 38 374-378.
21. Lord S.R., Ward J.A., Williams P. Exercise effect on dynamic stability in older women: a randomized controlled trial. Arch. Phys. Med. Rehabil. (1996) 77 232-236.
22. Katz S., Downs T.D., Cash H.R., Grotz R.C. Progress in development of the index of ADL. Gerontologist (1970) 10 20-30.
23. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist (1969) 9 179-186.
24. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. (1975) 12 189-198.
25. Jorm A.F. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol. Med. (1994) 24 145-153.
26. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. (2004) 256 183-194.
27. Roman G.C., Tatemichi T.K., Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 43 250-260.
28. McKeith I.G., Galasko D., Kosaka K. et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 47 1113-1124.
29. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 34 939-944.
30. Yesavage J.A., Brink T.L., Rose T.L. et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. (1982) 17 37-49.
31. Linjakumpu T.A., Hartikainen S.A., Klaukka T.J. et al. Sedative drug use in the home-dwelling elderly. Ann. Pharmacother. (2004) 38 2017-2022.
32. Taipale H.T., Bell J.S., Uusi-Kokko M., Lonnroos E., Sulkava R., Hartikainen S. Sedative load among community-dwelling people aged 75 years and older: a population-based study. Drugs Aging (2011) 28 913-925.
33. Harris M.G., Burgess P.M., Pirkis J., Siskind D., Slade T., Whiteford H.A. Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. Aust. N. Z. J. Psychiatry (2011) 45 249-260.
34. Ried L.D., Johnson R.E., Gettman D.A. Benzodiazepine exposure and functional status in older people. J. Am. Geriatr. Soc. (1998) 46 71-76.
35. Millan-Calenti J.C., Tubio J., Pita-Fernandez S. et al. Prevalence of functional disability in activities of daily living (ADL), instrumental activities of daily living (IADL) and associated factors, as predictors of morbidity and mortality. Arch. Gerontol. Geriatr. (2010) 50 306-310.
36. Cesari M., Onder G., Zamboni V. et al. Physical function and self-rated health status as predictors of mortality: results from longitudinal analysis in the ilSIRENTE study. BMC Geriatr. (2008) 8 34.
37. Gaugler J.E., Duval S., Anderson K.A., Kane R.L. Predicting nursing home admission in the U.S: a meta-analysis. BMC Geriatr. (2007) 7 13.
38. Kokras N., Dalla C., Papadopoulou-Daifoti Z. Sex differences in pharmacokinetics of antidepressants. Expert Opin. Drug Metab. Toxicol. (2011) 7 213-226.
39. Mangoni A.A., Jackson S.H. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br. J. Clin. Pharmacol. (2004) 57 6-14.
40. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants? Am. J. Psychiatry (2003) 160 1643-1650.
41. Jackson A., Stephens D., Duka T. Gender differences in response to lorazepam in a human drug discrimination study. J. Psychopharmacol. (2005) 19 614-619.
42. Terry D.F., Sebastiani P., Andersen S.L., Perls T.T. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch. Intern. Med. (2008) 168 277-283.
43. Hilmer S.N., Mager D.E., Simonsick E.M. et al. A drug burden index to define the functional burden of medications in older people. Arch. Intern. Med. (2007) 167 781-787.
44. Gnjidic D., Le Couteur D.G., Naganathan V. et al. Effects of Drug Burden Index on cognitive function in older men. J. Clin. Psychopharmacol. (2012) 32 273-277.
45. Wu C.S., Wang S.C., Chang I.S., Lin K.M. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am. J. Geriatr. Psychiatry (2009) 17 614-620.
46. Boeuf-Cazou O., Bongue B., Ansiau D., Marquie J.C., Lapeyre-Mestre M. Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur. J. Clin. Pharmacol. (2011) 67 1045-1052.
47. Lau H.S., de Boer A., Beuning K.S., Porsius A. Validation of pharmacy records in drug exposure assessment. J. Clin. Epidemiol. (1997) 50 619-625.
48. Bierman A.S., Pugh M.J., Dhalla I. et al. Sex differences in inappropriate prescribing among elderly veterans. Am. J. Geriatr. Pharmacother. (2007) 5 147-161.